Shuxin XI – Trademark Portfolio

Entity Type: 01

Shuxin XI holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 18 (Leather Goods) — 2 filings in this category. The portfolio also extends into Class 34 (Smokers Articles) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include AMGRIN, AMOLAR, and RICHLAND. The owner is based in Shenzhen, Guangdong.

2-7E, Haiyi Oriental Garden, No. 9

Gaoxin South Ring Road, Nanshan District

Shenzhen, Guangdong 518000 , CN

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

AMGRIN
AMGRIN
Registered 2024
AMGRIN
AMGRIN
Registered 2023
RICHLAND
RICHLAND
Registered 2023
AMOLAR
AMOLAR
Registered 2016

Trademark Classifications

Shuxin XI's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

18
Leather Goods (2 filings)

Leather and imitations of leather; animal skins, hides; trunks and travelling bags

34
Smokers Articles (2 filings)

Tobacco; smokers articles; matches

Frequently Asked Questions

How many trademarks does Shuxin XI have?

Shuxin XI has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.

What trademark classes does Shuxin XI file in?

Shuxin XI files trademarks across 2 Nice Classification classes. The most active classes are Class 18 (Leather Goods), Class 34 (Smokers Articles). Class 18 covers leather and imitations of leather; animal skins, hides; trunks and travelling bags.

What are Shuxin XI's most well-known trademarks?

Shuxin XI's registered trademark portfolio includes well-known marks such as AMGRIN, AMOLAR, and RICHLAND. These are among 4 currently registered trademarks in the portfolio.

What is Shuxin XI's trademark registration success rate?

Shuxin XI has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.